ArticleCancer epidemiology2026
Mapping melanoma in Hawai'i with inpatient discharge data from 2016 to 2023: Community determinants and anatomic distribution patterns.
Article in Cancer epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundHawai'i has above average rates of melanoma, with head and neck melanoma (HNM) considered the most severe. Analysis of discharge records can reveal disease patterns, and demographic and geographic disparities.
objectiveTo describe community and individual factors associated with Hawai'i's melanoma inpatients between 2016 and 2023.
methodsPatients diagnosed with melanoma were identified from inpatient discharge records filed between 2016 and 2023. Multivariable logistic regression identified factors associated with HNM for inpatients. Zero-truncated negative binomial regression examined factors associated with length of stay (LOS).
resultsOf 409 inpatients with melanoma diagnoses, 67 had it as a principal diagnosis. HNM was less likely to be a secondary diagnosis. HNM was more commonly observed among males, age > 80, or Maui residents. Among patients with principal diagnoses, non-White patients (including Native Hawaiian and Pacific Islanders (NH-PI)) were more likely to have longer LOS than White patients, as did those with more secondary diagnoses LIMITATIONS: The prevalence of melanoma in Hawai'i cannot be inferred, given the focus on inpatient data, along with the absence of data from the self-governed health systems. Melanoma subtypes were not analyzed due to insufficient data.
conclusionHospitalization for melanoma in Hawai'i was associated with male sex, age, and resident area. NH-PI, and those having a greater number of secondary diagnoses had longer LOS. CAPSULE SUMMARY:
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.